Direct Anterior Approach Versus Mini Posterior Approach Versous Lateral Approach for Displaced Femoral Neck Fractures

October 31, 2020 updated by: Vasileios S. Nikolaou, National and Kapodistrian University of Athens

Direct Anterior Approach (in Regular OR Table) Versus Mini Posterior Approach Versus Lateral Approach for the Treatment of Displaced Femoral Neck Fractures: A Prospective Randomized Trial

In general, hip fractures in the elderly are associated with a high one year-mortality up to 36 %. Apart from choosing the proper treatment, optimizing the surgical technique itself offers options to improve the outcome. Early mobilization after hip hemi¬arthroplasty correlates with improved ambulation, reduced need for assisted transfers, and less use of extended care facilities after hospital discharge.

Nowadays, in order to reduce soft tissue damage and gain quicker postoperative recovery and faster rehabilitation, various MIS techniques have been proposed. Two of these techniques are the mini posterior approach and the mini direct anterior approach. The direct anterior approach was developed as a true internervous and intermuscular surgical approach with proposed benefits of faster recovery, quicker return to function, and less pain. In theory, the direct anterior approach should cause less tissue damage than mini posterior approach, as it is performed through a plane between neurlogical tissue and intermuscular plane without muscle transection.

The aim of this study is to evaluate the clinical and radiological outcomes of the direct anterior approach for bipolar head endoprosthetic hemiarthroplasty in patients with displaced femoral neck fractures in comparison with the mini posterior approach and the traditional lateral approach, for the treatment of the same fractures. The investigators hypothesized that patients undergoing the direct anterior approach would have better clinical and radiological results in comparison with the mini posterior and lateral approach.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Consecutive patients undergoing hip fracture surgery for displaced femoral neck fractures (Garden 3 and 4 fractures) and treated by cemented hemiarthroplasty will be included in the study. Patients must have the ability to give informed consent or a legal guardian is available.

Exclusion Criteria:

  • The exclusion criteria include open or pathological fractures, re-fractures, infection, concomitant injuries of the ipsi- or contralateral leg or upper limb, skin diseases in the area of proposed incisions, patients that are mentally incapable of understanding the consequences of the study and reduced compliance.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Direct anterior approach
Patients with a femoral neck fracture, treated by hemiarthroplasty by direct anterior approach, using a regular OR table, without hip hyperextension.
Hemiarthroplasty to elderly patients with femoral neck fracture through a direct anterior approach
Active Comparator: Mini Posterior Approach
Patients with a femoral neck fracture, treated by hemiarthroplasty by a mini posterior approach.
Hemiarthroplasty to elderly patients with femoral neck fracture through a mini posterior approach
Active Comparator: Lateral approach
Patients with a femoral neck fracture, treated by hemiarthroplasty by a lateral (Hardinge) approach.
Hemiarthroplasty to elderly patients with femoral neck fracture through a lateral approach (Hardinge)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Five Item Barthel Index
Time Frame: 6 weeks post-surgery

Patient mobilization and motoric status measured with a five-item-Barthel index.

The Barthel scale is an ordinal scale used to measure performance in activities of daily living (ADL). Each performance item is rated on this scale with a given number of points assigned to each level or ranking. The Barthel Index is a widely used measure of physical dependence in personal activities of daily living (PADL). The short five-item Barthel index score ranges from 0-15 points, with 0 means the worst score and 15 the optimal score that a patient can achieve.

6 weeks post-surgery
The Five Item Barthel Index
Time Frame: 3 months post-surgery

Patient mobilization and motoric status measured with a five-item-Barthel index.

The Barthel scale is an ordinal scale used to measure performance in activities of daily living (ADL). Each performance item is rated on this scale with a given number of points assigned to each level or ranking. The Barthel Index is a widely used measure of physical dependence in personal activities of daily living (PADL). The short five-item Barthel index score ranges from 0-15 points, with 0 means the worst score and 15 the optimal score that a patient can achieve.

3 months post-surgery
The Timed Up and Go test (TUG)
Time Frame: 4 days after the surgery

The Timed Up and Go test, is a test of balance that is commonly used to examine functional mobility in community-dwelling, frail older adults. The test requires a subject to stand up, walk 3 m (10 ft), turn, walk back, and sit down. Time taken to complete the test is strongly correlated to the level of functional mobility.

Older adults who are able to complete the task in less than 20 seconds have been shown to be independent in transfer tasks involved in activities of daily living, and walk at gait speeds that should be sufficient for community mobility (0.5 m/s). In contrast, older adults requiring 30 seconds or longer to complete the task tend to be more dependent on activities of daily living and require assistive devices for ambulation.

4 days after the surgery
The Timed Up and Go test (TUG)
Time Frame: 6 weeks post surgery

The Timed Up and Go test, is a test of balance that is commonly used to examine functional mobility in community-dwelling, frail older adults. The test requires a subject to stand up, walk 3 m (10 ft), turn, walk back, and sit down. Time taken to complete the test is strongly correlated to the level of functional mobility.

Older adults who are able to complete the task in less than 20 seconds have been shown to be independent in transfer tasks involved in activities of daily living, and walk at gait speeds that should be sufficient for community mobility (0.5 m/s). In contrast, older adults requiring 30 seconds or longer to complete the task tend to be more dependent on activities of daily living and require assistive devices for ambulation.

6 weeks post surgery
Parker mobility score
Time Frame: One week before the fracture occur

Postoperative mobility score, as proposed by Parker and Palmer (Parker MJ, Palmer CR, JBJS Br (1993) ).

The Parker Mobility Score is a composite measurement of the patient's mobility indoors, outdoors and during shopping, and is used in studies either to measure the mobility as an outcome measure or as a predictor for mortality

Range 0-9 points (0 is the worst score and 9 the best score that a patient can achieve)

One week before the fracture occur
Parker mobility score
Time Frame: 3 months post surgery

Postoperative mobility score, as proposed by Parker and Palmer (Parker MJ, Palmer CR, JBJS Br (1993) ).

The Parker Mobility Score is a composite measurement of the patient's mobility indoors, outdoors and during shopping, and is used in studies either to measure the mobility as an outcome measure or as a predictor for mortality

Range 0-9 points (0 is the worst score and 9 the best score that a patient can achieve)

3 months post surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change to the Total blood loss (TBL)
Time Frame: Preop to day 4 post surgery
For calculation of the total blood loss (TBL) expressed to total Hb loss and total Volume loss , we will use the number of transfusions (55 grams of haemoglobin per transfusion), the haemoglobin concentration on preoperatively (Hgbi) and the haemoglobin concentration on the last available measure of haemoglobin concentration (Hgbe). (Hemoglobin balance method)
Preop to day 4 post surgery
Change at the Pain Visual Analog (VAS) score
Time Frame: From day one up to 6 weeks post surgery
The pain visual analog scale (VAS) is commonly used as the outcome measure for pain. It is presented as a 100-mm horizontal line on which the patient's pain intensity is represented by a point between the extremes of "no pain at all" (0 pain) and "worst pain imaginable." (100 pain)
From day one up to 6 weeks post surgery
Muscle Damage Markers
Time Frame: Daily for days 1-4 Post-op
CK (Creatine Kinase), ECR and CRP
Daily for days 1-4 Post-op
Change at Creatine Kinase (CK)
Time Frame: Daily for days 1-4 Post-op and at 6 weeks post-op

The appearance of creatine kinase (CK) in blood has been generally considered to be an indirect marker of muscle damage.

Reference Values Males >3 months: 39-308 U/L Females >3 months: 26-192 U/L

Daily for days 1-4 Post-op and at 6 weeks post-op
Change at C-Reactive protein (CRP)
Time Frame: Daily for days 1-4 Post-op and at 6 weeks post-op

C-reactive protein (CRP) levels have been documented as a potent marker for skeletal muscle damage.

Reference Value: 0-10mg/L

Daily for days 1-4 Post-op and at 6 weeks post-op

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2020

Primary Completion (Anticipated)

December 30, 2021

Study Completion (Anticipated)

March 30, 2022

Study Registration Dates

First Submitted

June 17, 2020

First Submitted That Met QC Criteria

October 31, 2020

First Posted (Actual)

November 6, 2020

Study Record Updates

Last Update Posted (Actual)

November 6, 2020

Last Update Submitted That Met QC Criteria

October 31, 2020

Last Verified

October 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Fractures

Clinical Trials on Direct Anterior Approach Hemiarthroplasty

Subscribe